Data / Form D filings / OUROTECH, INC.- PEAR BIO
OUROTECH, INC.- PEAR BIO: Form D filings
OUROTECH, INC.- PEAR BIO, a biotechnology company in London, United Kingdom, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on April 14, 2023, reports $14.2 million sold of a $16.1 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 84 WOOD LANE, London, United Kingdom, W12 0
- Phone
- 44 771-655-8079
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1890185
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | New notice | $16,135,194 | $14,151,725 | $1,983,469 | 12 | Apr 3, 2023 | sec.gov |
| Oct 29, 2021 | New notice | $4,746,498 | $4,586,498 | $160,000 | 21 | Oct 15, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Uzma Choudry | Director | |
| Duleeka Ranatunga | Executive Officer, Director | |
| Rob Kniaz | Director |
Every Form D from the week of Apr 10, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OUROTECH, INC.- PEAR BIO reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.